- An MS clinical trial is a research study that tests whether a treatment is safe and works; taking part is voluntary and is not guaranteed treatment.
- Trials run in phases 1 through 4, testing safety, effectiveness, comparison with standard care, and long-term monitoring after approval.
- You can search ClinicalTrials.gov by condition and location, and the National MS Society offers resources and a helpline to guide participants.
- Informed consent means the team explains risks and benefits before you agree, and you may withdraw at any time without losing your regular care.
- Never stop a disease-modifying therapy (DMT) or other MS treatment to qualify for a study without your neurologist's guidance.
- MS is a lifelong condition managed by a neurologist; a trial is one option to weigh alongside proven care, not a replacement for it.
A clinical trial for multiple sclerosis (MS) is a research study that tests whether a treatment — a medication, a rehabilitation approach, or a device — is safe and helps people living with MS. Taking part is voluntary, it is not the same as receiving proven care, and you can leave at any time. This guide explains what MS trials are, how the phases work, how to search for one, and how to weigh the decision with your neurologist. It is educational and does not replace medical advice.
MS is a lifelong neurological condition, and the disease-modifying therapies that now shape treatment were proven through trials that volunteers made possible. Exploring research is a reasonable, informed step for many people with MS, and it says nothing negative about you or how your condition is being managed.
What a clinical trial actually is
As MedlinePlus and the NIH describe it, a clinical trial is a research study that tests how well a new medical approach works in people, guided by a written plan called a protocol. An Institutional Review Board (IRB) — clinicians, statisticians, and community members — reviews and monitors each study to protect participants and check that the possible benefits justify the risks. Many trials compare a new treatment against standard care or a placebo, and often use randomization, so a computer, not the researcher, assigns your group. For a fuller primer, see how clinical trials work.
The four phases, briefly
Trials run in phases, each answering a different question. This framework comes from the NIH.
| Phase | Main question | Typical size |
|---|---|---|
| Phase 1 | Is it safe? What dose is tolerable? | Small (roughly 20–80 people) |
| Phase 2 | Does it work, and is it still safe? | Larger (roughly 100–300) |
| Phase 3 | How does it compare with standard treatment? | Large (hundreds to thousands) |
| Phase 4 | How does it perform long-term after approval? | Ongoing, post-approval |
MS research spans all four phases and many approaches — new disease-modifying therapies, treatments aimed at repair or remyelination, symptom and rehabilitation studies, and early work such as CAR T-cell studies that the National MS Society has highlighted.
How to search for an MS trial
The main public database is ClinicalTrials.gov, run by the U.S. National Library of Medicine. Each study record shows recruitment status, eligibility criteria, locations, and contacts, plus a unique NCT number. To search:
- Enter “multiple sclerosis” (or a subtype such as “relapsing-remitting MS”) and your city or state.
- Filter by recruitment status to see studies actively enrolling.
- Read the eligibility criteria, which often depend on your MS type, disability level, and current treatments.
- Use the listed contact to reach the study team with your questions.
The National Multiple Sclerosis Society provides resources to help you decide whether to participate, what to ask, and how to join a study, and can be reached at 1-800-344-4867. The NINDS also points people to ClinicalTrials.gov and to “NIH Clinical Research Trials and You.” Your neurologist is often the best first contact, since MS centers frequently run trials.
Informed consent and your right to withdraw
Before enrolling, the study team must take you through informed consent: a process in which they explain the purpose, procedures, possible risks and benefits, and your alternatives. Take the form home, ask questions, and involve your neurologist or a family member. Consent is not a lock-in — you have the right to withdraw at any time, for any reason, without penalty and without losing the standard care you would otherwise receive.
Research is not guaranteed treatment
A trial may test something that turns out not to help, and you may be assigned to a comparison or placebo group. Enrolling does not guarantee your MS will improve, and it should not replace proven care. Think of a trial as one possibility to weigh alongside your neurologist’s recommended treatment plan, not a substitute for it.
Never stop your current treatment on your own
Disease-modifying therapies work by steadily reducing MS activity, and stopping one can allow the disease to become more active. Do not quit a DMT or another MS treatment to qualify for a study on your own. If a trial requires a change to your medications, your neurologist and the study team should plan it together. The safe order is: explore eligibility first, change nothing until a clinician guides it.
Frequently asked questions
Is it safe to join an MS clinical trial?
Trials follow a protocol reviewed and monitored by an Institutional Review Board to protect participants, but no research is risk-free. The consent process explains the specific risks so you can decide. Review any trial with your neurologist first.
Will I get a placebo instead of real treatment?
Some MS trials include a placebo or a comparison group, and assignment is often random, though study design varies. The consent form states whether a placebo is possible — ask the study team directly before agreeing.
Does it cost money to participate?
Study treatment is often provided at no cost and some trials cover travel, while other costs vary and may involve your insurance. Ask the study team exactly what is covered before you enroll.
Can I leave the study after I start?
Yes. You can withdraw at any time, for any reason, without penalty and without losing your usual medical care. Tell the study team so any study treatment can be stopped safely.
Do I have to stop my DMT to qualify?
Not on your own. Never stop or change a disease-modifying therapy to join a study without your neurologist’s guidance, because stopping can let MS become more active. Let your clinician and the study team coordinate.
Where can I get help deciding?
The National Multiple Sclerosis Society (1-800-344-4867) offers resources on participating in trials, and your neurologist can point you to studies that fit your MS type and history.
This article is general education and is not medical advice. Talk to a qualified clinician about your situation.
Sources
- ClinicalTrials.gov — U.S. National Library of Medicine / National Institutes of Health (searching studies, phases, NCT numbers, eligibility)
- National Institutes of Health — “NIH Clinical Research Trials and You” (trial phases; informed consent)
- National Institute of Neurological Disorders and Stroke (NINDS) — multiple sclerosis and clinical trials information
- National Multiple Sclerosis Society — resources for participating in MS clinical trials; helpline 1-800-344-4867
- MedlinePlus, U.S. National Library of Medicine — Clinical Trials overview (protocol, IRB oversight)
Related reading: start with how clinical trials work, compare clinical trials for other neurological conditions and clinical trials for depression, and browse the full Medical Conditions guide.